Wednesday, March 05, 2025 | 01:36 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: Patent battles can choke Covid drugs pipeline

Efforts to avoid patent battles, a second wave in some cities, fresh research that sheds light on the virus, and more-news on how the country is coping with the pandemic

Coronavirus
Premium

A health worker collects a nasal sample from a woman for a Rapid Antigen Test (RAT) for the Covid-19 coronavirus in Srinagar.

Bharath Manjesh New Delhi
‘Patent battles could choke Covid-19 drugs pipeline’

India and South Africa are leading a call at the World Trade Organisation (WTO) for intellectual property (IP) exemptions on diagnostic kits, vaccines, medicines, personal protective equipment, and ventilators required to fight Covid-19. These exemptions from the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement would mean that WTO member countries would not necessarily need to grant or enforce intellectual property rights related to Covid-19 drugs, vaccines, diagnostics, and other technologies

In the context of Covid-19, intellectual property could be used adversely to cut off easy access to treatments and vaccines in developing

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in